Cardiol Therapeutics Inc
NASDAQ:CRDLView on Canadian Exchange

  • LAST PRICE
    2.1200
  • TODAY'S CHANGE (%)
    0.1200 (6.0000%)
  • Bid / Lots
    2.0700/ 12
  • Ask / Lots
    2.2000/ 1
  • Open / Previous Close
    2.0000 / 2.0000
  • Day Range
    1.9500
    2.2020
  • 52 Week Range
    0.6610
    3.1200
  • Volume
    726,406

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
CRDL
Cardiol Therapeutics Inc
184.6M
0.0x
---
As of 2024-06-25

Company Information

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

Contact Information

Headquarters
602-2265 Upper Middle Road EastOAKVILLE, ON, Canada L6H 0G5
Phone
289-910-0850
Fax
905-491-6793

Executives

No data available

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$184.6M
Revenue (TTM)
$0.00
Shares Outstanding
68.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.70
EPS
$-0.46
Book Value
$0.43
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.